30314968 |
Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer
Formisano, L,
Sudhan, DR,
Arteaga, CL,
Nagy, RJ,
Croessmann, S,
Kinch, LN,
Bernicker, EH,
Mathew, A,
Gonzalez-Ericsson, PI,
Grishin, NV,
Lanman, RB,
Cutler, RE,
Lalani, AS,
He, J,
Miller, VA,
Cristofanilli, M
|
Clin. Cancer Res. |
2019 |
23220880 |
Activating HER2 mutations in HER2 gene amplification negative breast cancer
Bose, R,
Shen, W,
Aronson, AB,
Goel, N,
Koboldt, DC,
Li, S,
Searleman, AC,
Ma, CX,
Ellis, MJ,
Shen, D,
Ding, L,
Monsey, J,
Mardis, ER,
Kavuri, SM
|
Cancer Discov |
2013 |